Please provide your email address to receive an email when new articles are posted on . IVUS-guided angioplasty for peripheral artery disease improved procedural outcomes vs. an angiography-guided ...

Compared with angiography alone, adding IVUS imaging to femoropopliteal artery interventions with drug-coated balloons (DCBs) results in less binary restenosis at 1 year, according to results from a ...

In a showdown of drug-coated balloons (DCBs) for peripheral artery disease, the investigational Chocolate Touch device came out superior on efficacy in an open-label randomized trial. Among over 300 ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

ATLANTA, GA—Patients with femoropopliteal artery disease see sustained improvements in primary patency through 1 year after drug-coated balloon (DCB) angioplasty if their procedures were done under ...

Please provide your email address to receive an email when new articles are posted on . In patients with complex peripheral artery disease, a drug-coated balloon performed similarly to how it did in ...

An FDA advisory committee turned thumbs down on Becton Dickinson's Lutonix 014 drug-coated balloon (DCB) for peripheral artery disease (PAD) during a virtual meeting on Wednesday. Circulatory System ...

Paris, France, 21 May 2019. This PCR statement on paclitaxel drug-coated balloons (DCB) use in peripheral interventions addresses the controversy raised by the meta-analysis of K. Katsanos, MD, PhD ...

Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...

The US Food and Drug Administration (FDA) has approved Boston Scientific's Ranger drug-coated balloon (DCB) for the treatment of peripheral artery disease, the company announced Monday. The paclitaxel ...

Peripheral artery disease (PAD) is a major cause of limb loss. It is estimated that PAD affects between 8.5 and 12 million Americans, with a prevalence that has increased by about 25 percent over the ...